Zardaverine

Zardaverine

CAT N°: 29685
Price:

From 48.00 40.80

Zardaverine is a dual inhibitor of phosphodiesterase 3 (PDE3) and PDE4 (IC50s = 0.617 and 1.738 ?M, respectively, for the rat cardiac ventricle enzymes).{46697} It is selective for PDE3 and PDE4 over PDE1B, PDE2, and PDE5 (IC50s = >138 ?M for all). Zardaverine inhibits aggregation of human platelets induced by ADP (Item No. 21121), platelet-activating factor (PAF), collagen, arachidonic acid (Item Nos. 90010 | 90010.1 | 10006607), or prostaglandin E1 (PGE1; Item No. 13010) and ADP (IC50s = 1.5-16.2 ?M). It inhibits zymosan-induced superoxide anion release from human polymorphonuclear (PMN) cells (IC50 = 0.4 ?M). Zardaverine (10 ?mol/kg) decreases lung resistance and increases dynamic compliance in a rat model of acetylcholine-induced bronchospasm.{46698} It decreases the viability of HeLa, COLO 741, NCI H2122, and A2058 cells that endogenously express high levels of PDE3A (IC50s = 0.032, 0.027, 0.26, and 0.13 ?M, respectively), but is inactive against a panel of eight cancer cell lines that express low levels of PDE3A (IC50s = >16 ?M for all).{46699}

We also advise you